Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humana Inc (HUM)

Humana Inc (HUM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,928,964
  • Shares Outstanding, K 120,054
  • Annual Sales, $ 129,664 M
  • Annual Income, $ 1,188 M
  • EBIT $ 3,402 M
  • EBITDA $ 4,226 M
  • 60-Month Beta 0.44
  • Price/Sales 0.16
  • Price/Cash Flow 7.28
  • Price/Book 1.19

Options Overview Details

View History
  • Implied Volatility 78.24% (+2.50%)
  • Historical Volatility 36.47%
  • IV Percentile 98%
  • IV Rank 74.64%
  • IV High 95.54% on 04/07/25
  • IV Low 27.33% on 08/20/25
  • Expected Move (DTE 2) 7.91 (4.76%)
  • Put/Call Vol Ratio 0.46
  • Today's Volume 8,931
  • Volume Avg (30-Day) 7,802
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 108,804
  • Open Int (30-Day) 104,291
  • Expected Range 158.10 to 173.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 9.89
  • Number of Estimates 11
  • High Estimate 10.43
  • Low Estimate 9.00
  • Prior Year 11.58
  • Growth Rate Est. (year over year) -14.59%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.11 +0.58%
on 03/20/26
189.50 -13.43%
on 03/02/26
-26.49 (-13.90%)
since 02/27/26
3-Month
163.11 +0.58%
on 03/20/26
285.61 -42.56%
on 01/15/26
-94.78 (-36.62%)
since 12/26/25
52-Week
163.11 +0.58%
on 03/20/26
315.35 -47.98%
on 09/05/25
-100.53 (-38.00%)
since 03/28/25

Most Recent Stories

More News
Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company...

HUM : 164.05 (-1.17%)
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know

Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know

ENOV : 21.69 (-0.60%)
HUM : 164.05 (-1.17%)
HIMS : 19.01 (+1.22%)
LFST : 6.24 (-1.27%)
NEOG : 8.81 (-1.12%)
1 Profitable Stock to Own for Decades and 2 We Question

1 Profitable Stock to Own for Decades and 2 We Question

TXT : 85.95 (unch)
HUM : 164.05 (-1.17%)
ORN : 10.65 (-2.11%)
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know

FTRE : 8.86 (-0.11%)
HUM : 164.05 (-1.17%)
PACB : 1.2996 (+3.14%)
ALHC : 17.01 (+0.95%)
DXCM : 62.52 (+1.00%)
Continuous Glucose Monitoring on the Rise Among Medicare Advantage Members with Type 2 Diabetes

Study by Humana Healthcare Research and Yale School of Medicine researcher reveals significant increase in CGM usage, particularly among older adults with chronic health conditions.

HUM : 164.05 (-1.17%)
Q4 Earnings Outperformers: Humana (NYSE:HUM) And The Rest Of The Health Insurance Providers Stocks

Q4 Earnings Outperformers: Humana (NYSE:HUM) And The Rest Of The Health Insurance Providers Stocks

HUM : 164.05 (-1.17%)
Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056,...

HUM : 164.05 (-1.17%)
Is Humana Stock Underperforming the S&P 500?

Humana has notably underperformed the S&P 500 over the past year, but analysts are moderately optimistic about the stock’s prospects.

HUM : 164.05 (-1.17%)
$SPX : 6,343.72 (unch)
CI : 260.60 (+0.98%)
AM Best Assigns Issue Credit Rating to Humana Inc.’s New Junior Subordinated Notes

AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to the $1 billion, 6.625% fixed rate junior subordinated notes, due 2056, of Humana Inc. (Humana) (headquartered in Louisville,...

HUM : 164.05 (-1.17%)
Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056,...

HUM : 164.05 (-1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental,...

See More

Key Turning Points

3rd Resistance Point 175.52
2nd Resistance Point 173.01
1st Resistance Point 169.51
Last Price 164.05
1st Support Level 163.50
2nd Support Level 160.99
3rd Support Level 157.49

See More

52-Week High 315.35
Fibonacci 61.8% 257.19
Fibonacci 50% 239.23
Fibonacci 38.2% 221.26
Last Price 164.05
52-Week Low 163.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.